|Bid||123.97 x 900|
|Ask||163.42 x 800|
|Day's Range||162.80 - 164.36|
|52 Week Range||122.78 - 164.45|
|Beta (5Y Monthly)||0.71|
|PE Ratio (TTM)||149.18|
|Earnings Date||Feb 02, 2020|
|Forward Dividend & Yield||4.12 (2.52%)|
|Ex-Dividend Date||Dec 28, 2019|
|1y Target Est||171.80|
Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT and the first and longest-tenured owner, operator and developer uniquely focused on collaborative life science, technology and agtech campuses in AAA innovation cluster locations, is holding its first national AgTech Innovation Prize competition for startup and early-stage agtech and foodtech companies that demonstrate novel approaches to addressing agriculture-, food- and nutrition-related challenges. Alexandria LaunchLabs® – AgTech, the premier platform accelerating early-stage agtech company growth, is calling for innovators who are working across an array of areas to transform the food value chain, including crop enhancement and protection, digital and data solutions, animal health, breeding and genetics, next-generation farming, and food and supply chain solutions.
The seller converted the office space — leased heavily by local biotech companies — to lab suites, then sold the buildings just three years after buying them.
Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) announced today the closing of its previously announced underwritten public offering of 6,900,000 shares of the Company's common stock at a public offering price of $155.00 per share, including the 900,000 shares sold pursuant to the exercise in full of the underwriters' option to purchase additional shares of the Company's common stock. In connection with the offering, the Company entered into forward sale agreements, between the Company and each of Goldman Sachs & Co. LLC, Bank of America, N.A., Citibank, N.A., and JPMorgan Chase Bank, N.A., London Branch (together, the "forward purchasers").
Alexandria (ARE) intends to utilize capital raised from the public offering to fund its development projects and repay outstanding debt balances.
Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) announced today the pricing of its public offering of 6,000,000 shares of common stock at a price of $155.00 per share in connection with the forward sale agreements described below. The Company also granted the underwriters a 30-day option to purchase up to 900,000 additional shares. The offering is expected to close on or about January 9, 2020, subject to customary closing conditions.
Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) announced today that it is commencing an underwritten public offering of 6,000,000 shares of common stock, subject to market conditions, in connection with the forward sale agreements described below. The Company expects to grant the underwriters a 30-day option to purchase up to 900,000 additional shares.
The Business Times devoted our first print edition of the year to previewing the companies, people and trends to watch across the Bay Area's main industries in 2020. Here's a look at what to expect in biotech and health. People to Watch Jennifer Doudna, UC Berkeley: Will 2020 be the year when gene-editing CRISPR technology co-inventor Jennifer Doudna wins the Nobel Prize?
Partnerships between tech companies and those in health care and biotech will change how Americans use health care in the 2020s, experts predict.
Massachusetts life science companies were involved in $34 billion worth of mergers and acquisitions this year. Experts say next year will be even busier.
The 129-room hotel already has a preliminary operating agreement with Starwood Capital Group to open a 1 Hotel property near the arena.
The deal for the Mylan manufacturing facility comes as Alexandria Real Estate Equities continues plans for upward of 2.1 million square feet in San Carlos.
American Tower (AMT) hikes quarterly dividend by 6.3%. However, accelerated carrier consolidation-driven churn continues to be a near-term woe.
Mid-America Apartment Communities' (MAA) recent dividend hike of 4.2% will likely be sustainable given the company's financial strength.
The biotech company acquired its first Bay Area presence 15 years ago; now it's planning to move into a high-profile biotech-focused project.
Alexandria Real Estate Equities, Inc. (NYSE: ARE) today announced that the company will conduct a conference call and audio webcast on Tuesday, February 4, 2020, at 3:00 p.m. Eastern Time (ET), in conjunction with the release of its operating and financial results for the fourth quarter and year ended December 31, 2019. Alexandria will release its operating and financial results after the market closes on Monday, February 3, 2020.
In line with its strategy of sharing growth in cash flows from operating activities with stockholders, Alexandria Real Estate Equities (ARE) announces a 3% dividend hike.
Alexandria Real Estate Equities, Inc. (NYSE: ARE) today announced that its Board of Directors declared a quarterly cash dividend of $1.03 per common share for the fourth quarter of 2019. The dividend is payable on January 15, 2020, to shareholders of record on December 31, 2019. The common stock dividend for the year ended December 31, 2019, of $4.00 per common share represents an increase of 27 cents, or 7 percent, over the year ended December 31, 2018.
Alexandria Real Estate Equities (ARE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Alexandria Real Estate Equities (ARE) launches an innovative and collaborative center that will focus on accelerating translation of therapeutic discoveries into important life-saving medicines.
Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT and the first and longest-tenured owner, operator and developer uniquely focused on collaborative life science, technology and agtech campuses in AAA innovation cluster locations, today announced the launch of a first-of-its-kind consortium to catalyze advanced biological innovation and manufacturing in Greater Boston. As a founding member of this consortium of top-tier academic institutions, research hospitals and life science industry partners in Massachusetts, Alexandria will serve on the board of directors alongside Harvard University, the Massachusetts Institute of Technology, FUJIFILM Diosynth Biotechnologies and GE Healthcare Life Sciences. Additional contributing members include Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, the Dana-Farber Cancer Institute, Massachusetts General Hospital, MilliporeSigma and the Commonwealth of Massachusetts. The powerful consortium has strategically convened to address the critical need for the development of important advanced technologies and to meet the region's strong demand for increased access to next-generation cell and viral vector manufacturing production, as well as to provide a novel and impactful workforce development platform to help accelerate the translation of emerging technologies into transformative medicines that aim to treat, prevent or even cure devastating diseases.
Amid solid demand for biotech real estate, Alexandria's (ARE) latest developments come as part of its strategic focus on expanding in San Carlos.
Alexandria Real Estate Equities has submitted plans for a 1.6 million-square-foot project in San Carlos, part of its potentially transformative Alexandria District for Science & Technology.
Local elections tend to draw less intensity and a smaller crowd than presidential and statewide contests, despite the ground-level impact of municipal officials. But this year’s elections have also attracted a super PAC with ties to Gov. Charlie Baker and donations from top Massachusetts executives.